{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:49:02Z","timestamp":1791478142353,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771542"],"award-info":[{"award-number":["81771542"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81300535"],"award-info":[{"award-number":["81300535"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Natural Science Foundation","award":["2017JY0021"],"award-info":[{"award-number":["2017JY0021"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2012017yjsy189"],"award-info":[{"award-number":["2012017yjsy189"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.metabol.2019.02.002","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T11:26:22Z","timestamp":1549970782000},"page":"47-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome"],"prefix":"10.1016","volume":"94","author":[{"given":"Meijiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangzhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongzhi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2019.02.002_bb0005","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-14-0253","article-title":"The polycystic ovary syndrome: a position statement from the European Society of Endocrinology","volume":"171","author":"Conway","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2019.02.002_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam EA-SPcwg","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.metabol.2019.02.002_bb0015","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s12020-016-0939-0","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia","volume":"54","author":"Ferri","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.metabol.2019.02.002_bb0020","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"Legro","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2019.02.002_bb0025","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3109\/09513590.2010.508852","article-title":"Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors","volume":"27","author":"Rocha","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.metabol.2019.02.002_bb0030","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/humrep\/deg440","article-title":"Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet","volume":"18","author":"Carmina","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.metabol.2019.02.002_bb0035","first-page":"126","article-title":"The dyslipidemia in women with polycystic ovary syndrome","volume":"30","author":"Zhang","year":"2011","journal-title":"J Int Reprod Health Fam Plan"},{"key":"10.1016\/j.metabol.2019.02.002_bb0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1210\/jc.2006-1705","article-title":"Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome","volume":"92","author":"Berneis","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2019.02.002_bb0045","first-page":"970","article-title":"Impaired ApoB-lipoprotein and triglyceride metabolism in obese adolescents with polycystic ovary syndrome","volume":"102","author":"Vine","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2019.02.002_bb0050","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1073\/pnas.0335507100","article-title":"The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation","volume":"100","author":"Seidah","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2019.02.002_bb0055","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.atherosclerosis.2014.12.017","article-title":"On the function and homeostasis of PCSK9: reciprocal interaction with LDLR and additional lipid effects","volume":"238","author":"Tavori","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2019.02.002_bb0060","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.114.301621","article-title":"PCSK9: a key modulator of cardiovascular health","volume":"114","author":"Seidah","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2019.02.002_bb0065","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/humu.20882","article-title":"Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease","volume":"30","author":"Abifadel","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.metabol.2019.02.002_bb0070","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1095\/biolreprod.109.082941","article-title":"Formation of the ovarian follicular antrum and follicular fluid","volume":"82","author":"Rodgers","year":"2010","journal-title":"Biol Reprod"},{"key":"10.1016\/j.metabol.2019.02.002_bb0075","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2741\/2065","article-title":"Molecular control of ovulation and luteinization in the primate follicle","volume":"12","author":"Stouffer","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.metabol.2019.02.002_bb0080","doi-asserted-by":"crossref","first-page":"s998","DOI":"10.2741\/1165","article-title":"Cholesterol uptake in adrenal and gonadal tissues: the SR-BI and \u2018selective\u2019 pathway connection","volume":"8","author":"Azhar","year":"2003","journal-title":"Front Biosci"},{"key":"10.1016\/j.metabol.2019.02.002_bb0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jri.2014.04.003","article-title":"Impact of maternal cholesterol metabolism on ovarian follicle development and fertility","volume":"104\u2013105","author":"van Montfoort","year":"2014","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.metabol.2019.02.002_bb0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/humupd\/dmp029","article-title":"High-density lipoprotein metabolism and the human embryo","volume":"16","author":"Fujimoto","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.metabol.2019.02.002_bb0095","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1210\/er.2001-0037","article-title":"The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues","volume":"24","author":"Rigotti","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2019.02.002_bb0100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1095\/biolreprod.114.120063","article-title":"High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome","volume":"91","author":"Lai","year":"2014","journal-title":"Biol Reprod"},{"key":"10.1016\/j.metabol.2019.02.002_bb0105","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.amjcard.2014.05.060","article-title":"Effect of alirocumab, a monoclonal proprotein convertase subtilisin\/kexin 9 antibody, on lipoprotein(a) concentrations (a pooled analysis of 150\u202fmg every two weeks dosing from phase 2 trials)","volume":"114","author":"Gaudet","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2019.02.002_bb0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jacl.2016.12.004","article-title":"Efficacy and safety of the proprotein convertase subtilisin\/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial hypercholesterolemia","volume":"11","author":"Kastelein","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.metabol.2019.02.002_bb0115","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1073\/pnas.96.16.9322","article-title":"Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology","volume":"96","author":"Trigatti","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl. B","key":"10.1016\/j.metabol.2019.02.002_bb0120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.placenta.2008.08.009","article-title":"Morphological selection of gametes","volume":"29","author":"Ubaldi","year":"2008","journal-title":"Placenta"},{"key":"10.1016\/j.metabol.2019.02.002_bb0125","first-page":"925691","article-title":"Paracrine regulation of steroidogenesis in theca cells by granulosa cells derived from mouse preantral follicles","volume":"2015","author":"Liu","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.metabol.2019.02.002_bb0130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/cen.12986","article-title":"Influence of race\/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study","volume":"85","author":"Chang","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.metabol.2019.02.002_bb0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.gene.2017.11.006","article-title":"Evaluation of PCSK9 levels and its genetic polymorphisms in women with polycystic ovary syndrome","volume":"644","author":"Xavier","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.metabol.2019.02.002_bb0140","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1194\/jlr.M051326","article-title":"Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin","volume":"55","author":"Kuhnast","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2019.02.002_bb0145","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0022-2275(20)35728-X","article-title":"Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans","volume":"34","author":"Dietschy","year":"1993","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2019.02.002_bb0150","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.22354","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration","volume":"48","author":"Zaid","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2019.02.002_bb0155","first-page":"675","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) in lipid metabolism, atherosclerosis and ischemic stroke","volume":"126","author":"Zhang","year":"2016","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.metabol.2019.02.002_bb0160","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1194\/jlr.R026658","article-title":"The PCSK9 decade","volume":"53","author":"Lambert","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2019.02.002_bb0165","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1126\/science.1125884","article-title":"Biomedicine. Lowering LDL\u2014not only how low, but how long?","volume":"311","author":"Brown","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.metabol.2019.02.002_bb0170","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00109-007-0172-7","article-title":"The proprotein convertases are potential targets in the treatment of dyslipidemia","volume":"85","author":"Seidah","year":"2007","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.metabol.2019.02.002_bb0175","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1358\/dot.2015.51.12.2435830","article-title":"Alirocumab: targeting PCSK9 to treat hypercholesterolemia","volume":"51","author":"Pecin","year":"2015","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.metabol.2019.02.002_bb0180","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1586\/14779072.2014.954551","article-title":"Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction","volume":"12","author":"Tavori","year":"2014","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.metabol.2019.02.002_bb0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0022-2275(20)40127-0","article-title":"Aberrant hypothalamic-pituitary-ovarian axis in the Watanabe heritable hyperlipidemic rabbit","volume":"35","author":"Robins","year":"1994","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2019.02.002_bb0190","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/jcem-49-5-687","article-title":"The production of progesterone, androgens, and estrogens by granulosa cells, thecal tissue, and stromal tissue from human ovaries in vitro","volume":"49","author":"McNatty","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2019.02.002_bb0195","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1071\/RD13436","article-title":"Low-density lipoprotein receptor affects the fertility of female mice","volume":"27","author":"Guo","year":"2015","journal-title":"Reprod Fertil Dev"},{"key":"10.1016\/j.metabol.2019.02.002_bb0200","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/jmf.2017.4069","article-title":"Black raspberry extract enhances LDL uptake in HepG2 cells by suppressing PCSK9 expression to upregulate LDLR expression","volume":"21","author":"Song","year":"2018","journal-title":"J Med Food"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049519300356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049519300356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:19:50Z","timestamp":1758428390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049519300356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":40,"alternative-id":["S0026049519300356"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2019.02.002","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2019.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}